Summary by Moomoo AI
Biora Therapeutics, Inc. (Biora Therapeutics) has announced its 2024 Annual Meeting of Stockholders to be held virtually on June 5, 2024. The meeting will address several key proposals, including the election of six director nominees to serve until the 2025 Annual Meeting, the ratification of KPMG LLP as the independent auditor for the fiscal year ending December 31, 2024, and an amendment to increase the number of authorized shares of common stock from 164,000,000 to 300,000,000. Additionally, the meeting will authorize the issuance of shares of common stock underlying certain warrants issued pursuant to a Securities Purchase Agreement dated March 31, 2024, and Warrant Amendment Agreements of the same date, in compliance with Nasdaq Listing Rule 5635(d). The Board of Directors has fixed April 16, 2024, as the record date, and only stockholders of record at the close of business on that date are entitled to notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof. The meeting will be conducted exclusively online via live audio webcast.